C3 glomerulonephritis with genetically confirmed C3 deficiency in a pediatric patient: a case report
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Complement component 3 glomerulonephritis (C3GN) is a rare kidney disease characterized by complement dysregulation that results in prominent complement component 3 (C3) deposition in the kidneys. The clinical course of C3GN varies from mild hematuria to progressive chronic kidney disease. In most patients, C3GN is driven by acquired factors, namely, autoantibodies that target C3 or C5 convertases. Genetic variations in complement-related genes are less frequent. We report the case of a 9-year-old Korean boy who presented with microscopic hematuria and a persistently low C3 level and had biopsy findings of C3GN, with the presence of a C3 gene mutation: a frameshift mutation associated with C3 deficiency. However, the patient did not exhibit any other symptoms of complement deficiency. Direct DNA sequencing of his family members revealed the same genetic mutation in his father and older brother. This case report is significant because there are very few such reports worldwide concerning gene mutations related to C3 deficiency to be discovered in patients with C3GN. Explaining C3GN pathogenesis is challenging; therefore, additional research is required in the future.
Abstract
Complement component 3 glomerulonephritis (C3GN) is a rare kidney disease characterized by complement dysregulation that results in prominent complement component 3 (C3) deposition in the kidneys. The clinical course of C3GN varies from mild hematuria to progressive chronic kidney disease. In most patients, C3GN is driven by acquired factors, namely, autoantibodies that target C3 or C5 convertases. Genetic variations in complement-related genes are less frequent. We report the case of a 9-year-old Korean boy who presented with microscopic hematuria and a persistently low C3 level and had biopsy findings of C3GN, with the presence of a C3 gene mutation: a frameshift mutation associated with C3 deficiency. However, the patient did not exhibit any other symptoms of complement deficiency. Direct DNA sequencing of his family members revealed the same genetic mutation in his father and older brother. This case report is significant because there are very few such reports worldwide concerning gene mutations related to C3 deficiency to be discovered in patients with C3GN. Explaining C3GN pathogenesis is challenging; therefore, additional research is required in the future.
참고문헌 (15)
- Kim YJ, "Pathology of C3 glomerulonephritis", J Korean Soc Pediatr Nephrol, 17, pp.1~5 (2013)
- Appel GB, "C3 glomerulopathy : a new disease comes of age", Mayo Clin Proc, 93, pp.968~969 (2018)
- Sethi S, "C3 glomerulonephritis : clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up", Kidney Int, 82, pp.465~473 (2012)
- Smith RJH, "C3 glomerulopathy : understanding a rare complement-driven renal disease", Nat Rev Nephrol, 15, pp.129~143 (2019)
- Servais A, "C3 glomerulopathy", Contrib Nephrol, 181, pp.185~193 (2013)
- Ravindran A, "C3 glomerulopathy : ten years' experience at Mayo Clinic", Mayo Clin Proc, 93, pp.991~1008 (2018)
- Schroder-Braunstein J, "Complement deficiencies and dysregulation : Pathophysiological consequences, modern analysis, and clinical management", Mol Immunol, 114, pp.299~311 (2019)
- Martinez-Barricarte R, "Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation", J Clin Invest, 120, pp.3702~3712 (2010)
- Xiao X, "C3 glomerulopathy : the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis", Semin Thromb Hemost, 40, pp.465~471 (2014)
- Barbier M, "MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections", Am J Hum Genet, 95, pp.736~743 (2014)
- Li Y, "Evaluating the monogenic contribution and genotype-phenotype correlation in patients with isolated thoracic aortic aneurysm", Eur J Hum Genet, 29, pp.1129~1138 (2021)
- Zhang H, "Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices", J Cell Biol, 124, pp.855~863 (1994)
- Okura Y, "Clinical characteristics and genotype-phenotype correlations in C3deficiency", J Allergy Clin Immunol, 137, pp.640~644 (2016)
- Kida M, "The first confirmed case with C3 deficiency caused by compound heterozygous mutations in the C3 gene; a new aspect of pathogenesis for C3deficiency", Blood Cells Mol Dis, 40, pp.410~413 (2008)
- Bomback AS, "Eculizumab for dense deposit disease and C3 glomerulonephritis", Clin J Am Soc Nephrol, 7, pp.748~756 (2012)